Author:
Fritze D.,Queißer W.,Illiger H. J.,Becher R.,Senn H. J.,Mayr A. C.,Jungi W. F.,Drings P.,Westerhausen M.,Massner B.,Abel U.,Edler L.
Publisher
Springer Berlin Heidelberg
Reference4 articles.
1. Fritze D, Becher R, Maßner B, Kaufmann M, Bruntsch U, Gallmeier WM, Mayr AC, Drings P, Abel U, Edler L, Jungi WF, Queißer W, Senn HJ (1982) A randomized study of combination chemotherapy (VAC/FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer. Klin Wschr 50: 593–598
2. Israel L, Edelstein R (1977) Personal experience with Corynebacterium parvum in human cancers. World J Surgery 1: 585–594
3. Milas L, Scott MT (1978) Antitumor effect of Corynebacterium parvum. Adv Cancer Res 26: 257
4. Pinsky CM, DeJager RL, Wittes RE, Wong PP, Kaufmann RJ, Mike V, Hansen JA, Oettgen HF, Krakoff IH (1978) Corynebacterium parvum as adjuvant to combination chemotherapy in patients with advanced breast cancer: Preliminary results of a prospective randomized trial. In: Terry WD, Windhorst D (eds) Immunotherapy of Cancer: Present Status of Trials in Man. Raven Press, New York 647–654